Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-18-001570
Filing Date
2018-02-15
Accepted
2018-02-15 06:16:52
Documents
1
Period of Report
2018-02-15

Document Format Files

Seq Description Document Type Size
1 SELUMETINIB IN NF1 GETS FDA ORPHAN DRUG STATUS a9703e.htm 6-K 42544
  Complete submission text file 0001654954-18-001570.txt   43669
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 18616058
SIC: 2834 Pharmaceutical Preparations